Hospice & palliative care

The Money Trails Worth Knowing About

Save

Most families meet a hospice through an intermediary: a discharge planner, a nursing-home administrator, a marketer at the kitchen table. Each of those paths carries its own economics. Understanding how the per-day payment works, and where the relationships sit, turns a vulnerable moment into an informed decision.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

How is a hospice actually paid?

Medicare pays a hospice a set amount for every day a patient is enrolled — a per-diem — rather than paying for each visit or service delivered 1. Eligibility runs through Medicare Part A: the patient must be entitled to Part A and certified terminally ill 1. From the day of election forward, the daily payments flow whether a given day held three visits or none.

That single design choice explains most of what follows on this page. A per-diem rewards enrolled days: more days enrolled means more payment days, and a patient whose care costs less than the daily rate is financially better for the agency than one whose care costs more. None of this is hidden or improper — it is simply how the benefit is built 1. But it shapes incentives the way any payment structure does, and families deserve to see the shape before they are standing inside it.

Where do the enrollment incentives sit?

In three places, mostly. At the front door: an agency grows by enrolling patients, so the person who introduces a family to a specific hospice may be part of that hospice's growth strategy rather than a neutral advisor. In patient selection: because the payment is daily and flat, a stable patient who needs few visits generates margin, while a patient in frequent crisis consumes it. In length of stay: a patient enrolled for months generates many more payment days than one enrolled for a week.

These are structural observations, not accusations. The same per-diem design is also what funds unhurried bedside time that visit-by-visit billing rarely allows — the structure cuts both ways. The point is narrower and more practical: when someone urges enrollment with a particular agency, it is fair to ask, calmly and out loud, what the urging is worth to them.

Why does the nursing-home relationship deserve a closer look?

Because the finances intertwine. For a nursing-facility resident who qualifies for both Medicare and Medicaid, Medicaid pays a room-and-board rate — commonly around 95% of the facility's rate, though the rules vary by state — and that payment passes through the hospice to the facility 2. The hospice bills; the facility receives; the two organizations become financial partners in the same resident's care.

Most of these partnerships are ordinary and appropriate. Hospices genuinely serve facility residents, and doing it well requires a working relationship. But the arrangement means a facility recommending "its" hospice is not a neutral referee, and a family is entitled to know that before treating the recommendation as vetted. Three questions clarify the ground: How many different hospices currently serve residents of this facility? May we have all of their names? Does the facility have a business relationship with the one being suggested?

Who suggested this hospice — and what do they stand to gain?

The referral path is the single most useful thing to examine. A hospital discharge planner hospice list, a physician's suggestion, a facility administrator's endorsement, a marketer who arrived uninvited — each path carries different economics, and none of them obligates the family.

A reasonable approach travels in three steps. Ask any referrer for more than one name; a source with nothing to gain rarely minds. Ask directly whether they or their employer have a relationship with the agency being suggested; the reaction to the question is often more informative than the answer. And treat an unsolicited pitch — someone recruiting a patient rather than a family seeking care — as a reason to slow down rather than a convenience. A separate page catalogs hospice sales red flags in detail, and another takes up what to do when hospice enrollment feels too fast.

Neither caution means hospice itself is suspect. It means the moment of choosing deserves the same scrutiny a family would give any consequential decision made under stress — which is exactly the condition this decision is usually made in.

What does signing actually change?

Electing the hospice benefit means Medicare stops paying for treatment intended to cure the terminal illness; care reorients around comfort 3. That is the trade at the center of the decision, and a trustworthy admission conversation states it plainly. An enrollment pitch that reaches the signature page without ever saying it has skipped the central fact — and that omission is itself a conflict-of-interest signal, because the agency benefits from the enrollment whether or not the family understood it.

The trade is also reversible, which changes the emotional stakes. A patient can leave hospice, return to curative treatment, and elect hospice again later 4. The signature is consequential, but it is not a trapdoor. A family being pressed with now-or-never framing is being sold, not informed — the ability to leave and return means the benefit itself imposes no such ultimatum 4.

Does ownership change the incentives?

The per-diem arrives the same way regardless of who owns the agency. What differs is where any margin goes and who answers for the pressure to produce it. An agency may be a community nonprofit or part of a national chain, and some are held by investment firms — private equity owned hospices are examined on their own page. Whether hospice margins and quality move together is likewise a question with an evidence base of its own, covered separately.

For a family choosing an agency, ownership is a question to ask rather than a verdict to assume: Who owns this hospice? Has the ownership changed recently? Is the medical director employed by the agency or independent of it? The answers matter less than how forthcoming they are. An agency that treats its own ownership as awkward information has told you something useful.

Which public counterweights exist?

Two federal mechanisms watch hospice quality from outside the agency's own marketing. The Hospice Quality Reporting Program collects standardized assessments, family-caregiver surveys, and claims-based measures from Medicare-certified hospices and feeds them into public reporting 5. And the CAHPS Hospice Survey goes directly to the people best positioned to judge: primary caregivers of patients who died, surveyed months afterward about help with symptoms, communication, timeliness of help, an overall rating, and whether they would recommend the agency 6.

Neither mechanism was designed as a conflict-of-interest detector, but both blunt the incentives described above. An agency that enrolls aggressively and staffs thinly will eventually wear it in survey results any family can read. The published numbers are not a verdict on any single case — they are averages — but they are independent of the referral path, which is precisely what makes them valuable to a family whose introduction to the agency came through an interested party.

What does a clean referral look like?

It has a recognizable shape. The referrer offers more than one name without being asked twice. Relationships are disclosed matter-of-factly — "we work with several agencies; here is how we know them." The family is given time to compare, and nobody suggests the window is closing. The admission conversation explains, unprompted, that hospice reorients care around comfort and that Medicare stops covering curative treatment for the terminal illness 3. No gifts, no incentives to sign, no urgency the medical facts don't supply.

A family that wants to prepare can bring the comparison to the meeting: published survey results reviewed in advance, and a written list of hospice admission questions — a separate page collects the ones worth asking. The goal is not adversarial. Most hospice teams do this work because they believe in it, and a good agency is at its most persuasive when a family arrives informed. The money trails are worth knowing precisely so they can stop mattering.

Common questions

Not inherently. Facilities coordinate closely with hospices and often know which agencies serve their residents well. The concern is exclusivity and disclosure: a facility that names only one option, or bristles at the question of whether a business relationship exists, has turned a recommendation into a referral pipeline. Asking for several names is always reasonable.

Under the per-diem structure, more enrolled days do mean more payment days. That is a fact about how the benefit is designed, not evidence that any particular agency manipulates enrollment. It is, though, a reason eligibility should be explained clearly — a family deserves to hear why the patient qualifies, in words that make sense to them.

Hospice election is not permanent. A patient can stop hospice, return to curative treatment, and elect the benefit again later. Families can also explore changing agencies. The immediate step is often a direct conversation with the hospice about what felt wrong — and, in parallel, a look at other agencies' published survey results.

Job titles blur, but the behavior separates them: a clinician assesses and answers; a marketer urges and closes. Someone who arrives uninvited, offers incentives to enroll, or resists the words "we want to compare agencies first" is performing sales, whatever the badge says. A clinical visit leaves a family knowing more; a sales visit leaves them feeling hurried.

No. The same payment structure that creates enrollment incentives also funds the team-based comfort care hospice exists to provide. The point of following the money is not to avoid hospice — it is to choose the agency on the family's terms rather than the referrer's, with the relationships visible instead of assumed.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a sales conversation crosses a line

  • Enrollment paperwork presented for signature before anyone has explained that hospice replaces curative treatment for the terminal illness
  • An offer of gifts, cash, or "free" services in exchange for signing, or recruitment of a person who has no terminal diagnosis
  • Pressure to sign the same day, before other agencies can be compared
  • A facility or referrer who refuses to name more than one hospice option when asked

This page is general education about how hospice is paid and referred, not legal or medical advice for any specific situation. Enrollment decisions belong with the patient, the family, and clinicians they trust.

References

  1. 1.Centers for Medicare & Medicaid Services (2024). Hospice (Fee-for-Service Providers). Centers for Medicare & Medicaid Services (CMS). linkThat Medicare pays hospices under a per-diem payment structure, and that eligibility requires the beneficiary to be entitled to Part A and certified terminally ill.
  2. 2.Centers for Medicare & Medicaid Services (2024). Hospice Payments (Medicaid). Medicaid.gov (CMS). linkThat for dually eligible nursing-facility residents, Medicaid pays a room-and-board rate (commonly about 95% of the facility rate) that is passed through the hospice to the facility, with rules varying by state.
  3. 3.Centers for Medicare & Medicaid Services (2024). Hospice Care Coverage. Medicare.gov (CMS). linkThat electing the Medicare hospice benefit means Medicare stops covering treatment intended to cure the terminal illness and care focuses on comfort.
  4. 4.National Institute on Aging (NIH) (2024). Frequently Asked Questions About Hospice Care. National Institute on Aging (NIH). linkThat patients can leave hospice, return to curative treatment, and elect hospice again later.
  5. 5.Centers for Medicare & Medicaid Services (2024). Hospice Quality Reporting Program. Centers for Medicare & Medicaid Services (CMS). linkThat the Hospice Quality Reporting Program collects standardized assessments, caregiver surveys, and claims-based measures from Medicare-certified hospices that feed public reporting.
  6. 6.Centers for Medicare & Medicaid Services (2024). CAHPS Hospice Survey. Centers for Medicare & Medicaid Services (CMS). linkThat the CAHPS Hospice Survey samples primary caregivers of deceased hospice patients months after the death and measures help for symptoms, communication, timeliness, overall rating, and willingness to recommend.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy